# A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation

> **NCT02737306** · PHASE2 · TERMINATED · sponsor: **CytoDyn, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Graft Vs Host Disease

## Interventions

- **DRUG:** PRO 140
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02737306
- **Lead sponsor:** CytoDyn, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-05-14
- **Primary completion:** 2021-04-14
- **Final completion:** 2021-09-30
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study terminated due to lack of enrolment..
- **Last updated:** 2024-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02737306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02737306, "A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02737306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*